Female gender is associated with more periprocedural complications, adjunctive arterial procedures, and increased endoleaks but does not affect long-term reinterventions or survival. Further studies are warranted to elucidate the effect of gender on outcomes. These data should be considered when selecting EVAR for men and women.

Despite most EVAR patients being treated outside of IFU, there was no difference in outcomes with respect to all-cause mortality or aneurysm-related mortality. In addition, with the exception of perioperative blood transfusions, there was no association between IFU adherence and late-onset rupture, need for reintervention, rates of endoleak, aneurysm sac enlargement, or most other major complications.

No abstract

No abstract

Results: The total number of access procedures per year increased from 86 in 2007 to 181 in 2013. A mean of 72% autogenous access was achieved (range, 68%-81%) over the study period. Overall, 18% of patients required a second access creation during the period, with arteriovenous (AV) graft creation requiring the highest rate of secondary procedures at 23%. The most frequently performed secondary procedure following an AV graft creation was another AV graft creation, and 43% of secondary procedures were a new autogenous access. Autogenous access procedures paid an average of $635.53 per procedure, and nonautogenous access creations paid an average of $598.47 per procedure, with reimbursement rates of 27.2% and 30.2%, respectively.Conclusions: It is possible to achieve the >66% autogenous access goal set forth by the DOQI guidelines. Further analysis is required to determine the characteristics of our institution allowing us to achieve a higher rate than that reported for the United States as a whole. Our data suggest that similar results can be achieved nationally and should serve as a renewed goal for all dialysis access surgeons.